Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes

30 Jan 2002Ella M de Leon, Scott J Jacober, Jack D Sobel and Betsy Foxman

Improving glucose control and possibly modifying sexual behavior may reduce risk of Candida colonization, and potentially symptomatic infection, among women with diabetes.

Cross-section study
4 effects
101 subjects

Reported Outcomes

CausesOutcomeCertainty

Type 1 Diabetes Lymphatic outcome
Type 1 Diabetes
Lymphatic system

Candida (Fungus) Lymphatic outcome
Strong increased risk of Candida (Fungus)
Lymphatic system

Moderate evidence
240.0%

Type 2 Diabetes Lymphatic outcome
Type 2 Diabetes
Lymphatic system

Candida (Fungus) Lymphatic outcome
Strong increased risk of Candida (Fungus)
Lymphatic system

Moderate evidence
240.0%

Diabetes Lymphatic outcome
Diabetes
Lymphatic system

Candida (Fungus) Lymphatic outcome
Strong increased risk of Candida (Fungus)
Lymphatic system

Moderate evidence
240.0%

Antibiotics Manufactured risk & protective factor
Antibiotics
Manufactured

Candida (Fungus) Lymphatic outcome
Strong increased risk of Candida (Fungus)
Lymphatic system

Moderate evidence
350.0%